PROGNOSTIC SIGNIFICANCE OF TONSL EXPRESSION AND THE HOMOLOGOUS RECOMBINATION PATHWAY IN INTERMEDIATE-RISK PROSTATE CANCER RECURRENCE

被引：0

作者：

So, Jonathan ^{[1
]}

Chua, Melvin ^{[2
]}

Lalonde, Emilie ^{[3
]}

Mahamud, Osman ^{[1
]}

Berlin, Alejandro ^{[1
]}

Dal Pra, Alan ^{[4
]}

Orain, Michele ^{[5
]}

Hovington, Helene ^{[6
]}

Bergeron, Alain ^{[6
]}

Fradet, Yves ^{[6
]}

Tetu, Bernard ^{[5
]}

Meng, Alice ^{[2
]}

Zhang, Junyan ^{[2
]}

Zafarana, Gaetano ^{[2
]}

Pintilie, Melania ^{[2
]}

van der Kwast, Theodorus ^{[1
]}

Fraser, Michael ^{[2
]}

Boutros, Paul ^{[2
]}

Bristow, Robert G. ^{[2
]}

机构：

[1] Univ Toronto, Toronto, ON, Canada

[2] Princess Margaret Canc Ctr, Toronto, ON, Canada

[3] Ontario Inst Canc Res, Toronto, ON, Canada

[4] Univ Bern, Bern, Switzerland

[5] CHUQ, Quebec City, PQ, Canada

[6] Univ Laval, Quebec City, PQ, Canada

来源：

RADIOTHERAPY AND ONCOLOGY | 2016年 / 120卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

227

引用

页码：S82 / S83

页数：2

共 50 条

[21] The baseline recurrence risk of patients with intermediate-risk cervical cancer
Yoneoka, Yutaka
Kato, Mayumi Kobayashi
Tanase, Yasuhito
Uno, Masaya
Ishikawa, Mitsuya
Murakami, Takashi
Kato, Tomoyasu
OBSTETRICS & GYNECOLOGY SCIENCE, 2021, 64 (02) : 226 - 233
[22] Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer
Nathalie Harder
Maria Athelogou
Harald Hessel
Nicolas Brieu
Mehmet Yigitsoy
Johannes Zimmermann
Martin Baatz
Alexander Buchner
Christian G. Stief
Thomas Kirchner
Gerd Binnig
Günter Schmidt
Ralf Huss
Scientific Reports, 8
[23] The predictive value of semaphorins 3 expression in biopsies for biochemical recurrence of patients with low- and intermediate-risk prostate cancer
Li, K.
Chen, M. K.
Li, L. Y.
Lu, M. H.
Shao, Ch K.
Su, Z. L.
He, D.
Pang, J.
Gao, X.
NEOPLASMA, 2013, 60 (06) : 683 - 689
[24] Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer
Harder, Nathalie
Athelogou, Maria
Hessel, Harald
Brieu, Nicolas
Yigitsoy, Mehmet
Zimmermann, Johannes
Baatz, Martin
Buchner, Alexander
Stief, Christian G.
Kirchner, Thomas
Binnig, Gerd
Schmidt, Guenter
Huss, Ralf
SCIENTIFIC REPORTS, 2018, 8
[25] The significance of surgical staging in intermediate-risk endometrial cancer
Kwon, Janice S.
Mazgani, Mona
Miller, Dianne M.
Ehlen, Tom
Heywood, Mark
McAlpine, Jessica N.
Finlayson, Sarah J.
Plante, Marie
Stuart, Gavin C. E.
Carey, Mark S.
GYNECOLOGIC ONCOLOGY, 2011, 122 (01) : 50 - 54
[26] Testosterone Replacement in a Man with Intermediate-risk Prostate Cancer
Morales, Alvaro
EUROPEAN UROLOGY FOCUS, 2017, 3 (4-5): : 319 - 320
[27] Personalizing the Management of Men with Intermediate-risk Prostate Cancer
D'Amico, Anthony V.
EUROPEAN UROLOGY, 2013, 64 (06) : 903 - 904
[28] Improving the Stratification of Patients With Intermediate-risk Prostate Cancer
Stolzenbach, Lara Franziska
Nocera, Luigi
Colla-Ruvolo, Claudia
Tian, Zhe
Knipper, Sophie
Maurer, Tobias
Tilki, Derya
Graefen, Markus
Karakiewicz, Pierre I.
CLINICAL GENITOURINARY CANCER, 2021, 19 (02) : E120 - E128
[29] Radiation treatment for patients with intermediate-risk prostate cancer
Greene, David E.
Mayadev, Jyoti S.
Valicenti, Richard K.
THERAPEUTIC ADVANCES IN UROLOGY, 2012, 4 (03) : 113 - 124
[30] Personalization of Treatment Intensity for Intermediate-Risk Prostate Cancer
Zumsteg, Zachary S.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (03): : 744 - 746

← 1 2 3 4 5 →